Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Medicamen Organics Ltd

NSE: MEDIORG · Pharmaceuticals & Biotechnology · 25 announcements

Share price
₹24.55
Market cap
₹36.53 Cr
Revenue (annual)
₹22.63 Cr
Net profit (annual)
₹-4.02 Cr
P/E (TTM)
-9.1×Sector 47.3×
Promoter holding
54.89%
FII holding
0.05%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

13:55 IST NSE
Management Change

Medicamen Organics Management Change

Mr. Brijesh Kumar Chaubey has resigned as Executive Director of Medicamen Organics Limited. The resignation is effective July 20, 2026, due to family medical issues.

17:19 IST NSE
Management Change

Medicamen Organics Management Change

Medicamen Organics Limited has appointed Ms. Divya Sharma as Company Secretary, effective April 17, 2026. Ms. Sharma is an Associate member of the ICSI with over a decade of experience in corporate governance and statutory compliance across the manufacturing and IT sectors.

16:43 IST NSE
Management Change

Medicamen Organics Management Change

Medicamen Organics Limited has appointed Ms. Divya Sharma as Company Secretary and Compliance Officer, effective April 17, 2026. Ms. Sharma, an Associate Member of ICSI with over a decade of experience, succeeds the previous officer. The board approved the appointment based on the Nomination and Remuneration Committee's recommendation.

20:11 IST NSE
Management Change

Medicamen Organics Management Change

Medicamen Organics Limited announced the cessation of Varsha Bansal from her role as Company Secretary, effective April 16, 2026. This administrative change follows statutory disclosure requirements for key managerial personnel.

18:58 IST NSE
Management Change

Medicamen Organics Management Change

Ms. Varsha Bansal has resigned as the Company Secretary and Compliance Officer of Medicamen Organics Limited, effective April 16, 2026. The resignation was due to personal reasons. The company is in the process of identifying a suitable replacement for the Key Managerial Personnel role.